FDA Subjects Antibiotic to New Scrutiny
14th Nov 2006, 15:54 GMT
WASHINGTON (AP) -- A novel antibiotic linked to rare reports of severe liver problems, including several deaths, will be subjected to new scrutiny by federal health advisers, according to a document released Tuesday....
FDA Subjects Antibiotic to New Scrutiny related news:
- FDA Subjects Antibiotic to New Scrutiny — Health News: CBSnews.com
- In wake of deaths, FDA subjects antibiotic to new scrutiny — USATODAY.com Health - Top Stories
- FDA subjects antibiotic to new scrutiny (Associated Press) — Yahoo! Health: Health News
- FDA subjects antibiotic to new scrutiny (AP) — Yahoo! News: Health News
- FDA subjects antibiotic to new scrutiny in wake of reports of death and injury — WOODTV - Political News
- Sanofi-Aventis Antibiotic Under Scrutiny — WSJ.com: US Business
- Review of Sanofi Drug Is Sought — WSJ.com: US Business
- Volume 194, number 12: Antibiotic Selection May Contribute to Increases in Macrolide-Resistant Treponema pallidum — J Infect Dis Latest Issue
- Documentary specials take a hard look at tough subjects — The Seattle Times: Horse racing
- FDA should return to 'science-based' agency — News-Medical News Feed
Latest news from AP Top Health News At 10:37 a.m.:
- Health Care Costs Could Jump 10 Percent
- Want to Live to a Healthy 85? Stay Trim
- Student Says His Drug Test Is Foolproof
- FDA: Tamiflu Patients Need Monitoring
- Study Questions Radiation for Prostate
- Study Says Late Angioplasty Seems Futile
- Greeks Suffer Higher Rates of Obesity
- FDA Subjects Antibiotic to New Scrutiny
- Spain Nixes Burger King Ad
- Heart Valves Grown From Womb Fluid Cells